Ruxolitinib (Opzelura) for atopic dermatitis

Med Lett Drugs Ther. 2022 Jan 24;64(1642):12-13.
No abstract available

Keywords: Elidel; Eucrisa; Jakafi; Opzelura; Protopic; Xeljanz; adverse effects; atopic dermatitis; corticosteroids; crisaborole; dosage; drug interactions; efficacy; lactation; pimecrolimus; pregnancy; ruxolitinib; safety; tacrolimus; tofacitinib.

MeSH terms

  • Administration, Cutaneous
  • Dermatitis, Atopic / diagnosis
  • Dermatitis, Atopic / drug therapy*
  • Dermatitis, Atopic / enzymology
  • Dermatologic Agents / administration & dosage*
  • Dermatologic Agents / adverse effects
  • Humans
  • Janus Kinase Inhibitors / administration & dosage*
  • Janus Kinase Inhibitors / adverse effects
  • Nitriles / administration & dosage*
  • Nitriles / adverse effects
  • Pyrazoles / administration & dosage*
  • Pyrazoles / adverse effects
  • Pyrimidines / administration & dosage*
  • Pyrimidines / adverse effects
  • Skin / drug effects*
  • Skin / enzymology
  • Skin / pathology
  • Treatment Outcome

Substances

  • Dermatologic Agents
  • Janus Kinase Inhibitors
  • Nitriles
  • Pyrazoles
  • Pyrimidines
  • ruxolitinib